Get the Stockscreener App
25.69
0.83%
-0.216
After Hours:
25.60
-0.091
-0.35%
Tema Oncology Etf Stock (CANC) Forecast
The Tema Oncology Etf (CANC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $30.95, representing a +20.45% increase from the current price of $25.69. The highest analyst price target is $32.26, and the lowest is $29.63.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CANC Price Target
Average 34.98
(+36.17% Upside)
Is Tema Oncology Etf (CANC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.87 | Neutral |
| STOCH(9,6) | 81.12 | Sell |
| STOCHRSI(14) | 83.27 | Sell |
| MACD(12,26) | 0.0684 | Buy |
| ADX(14) | 19.81 | Neutral |
| William %R | -19.58 | Sell |
| CCI(14) | 94.51 | Neutral |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
25.43
Buy
|
25.45
Buy
|
| MA20 |
25.04
Buy
|
25.29
Buy
|
| MA50 |
25.67
Buy
|
25.74
Sell
|
| MA100 |
26.99
Sell
|
26.46
Sell
|
| MA200 |
27.40
Sell
|
26.69
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CANC could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CANC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 55.87 indicates that CANC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 81.12 indicates that CANC is oversold. This means that CANC price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 83.27 indicates that CANC is oversold. This suggests that CANC price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.81 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 94.51 indicates that CANC is still overbought but not to an extreme extent.
Long-term CANC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tema Oncology Etf financial reports and earnings history, Tema Oncology Etf (CANC) stock could reach $59.91 by 2030, $124.09 by 2040 and $172.15 by 2050. See the projected annual prices until 2050 of the Tema Oncology Etf stock below:
- Tema Oncology Etf (CANC) is expected to reach an average price of $91.27 in 2035, with a high prediction of $91.55 and a low estimate of $89.49. This indicates an $255.27% rise from the last recorded price of $25.69.
- Tema Oncology Etf (CANC) stock is projected to chart a bullish course in 2040, with an average price target of $123.72, representing an $381.59% surge from its current level. The forecast ranges from a conservative $122.98 to a sky-high $124.09.
- Our analysts predict Tema Oncology Etf (CANC) to jump 439.45% by 2045, soaring from $137.77 to an average price of $138.59, potentially reaching $156.31. While $137.77 is the low estimate, the potential upside is significant.
- Tema Oncology Etf (CANC) stock is expected to climb by 2050, reaching an average of $172.15, a $570.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $172.15 and $167.73, respectively, highlighting the market's uncertainty.
Tema Oncology Etf Stock (CANC) Year by Year Forecast
Tema Oncology Etf Stock (CANC) Price Forecast for 2025
Tema Oncology Etf Stock (CANC) is expected to reach an average price of $33.69 in 2025, with a high prediction of $38.58 and a low estimate of $28.80. This indicates an +31.12% rise from the last recorded price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $32.26 | $29.63 | $32.26 | +25.56% |
| April, 2025 | $34.15 | $31.93 | $34.62 | +32.91% |
| May, 2025 | $34.22 | $33.46 | $34.89 | +33.20% |
| June, 2025 | $36.19 | $34.31 | $36.25 | +40.87% |
| July, 2025 | $35.84 | $35.22 | $37.40 | +39.52% |
| August, 2025 | $33.77 | $33.76 | $36.53 | +31.46% |
| September, 2025 | $34.32 | $33.61 | $35.88 | +33.59% |
| October, 2025 | $34.63 | $32.57 | $34.74 | +34.81% |
| November, 2025 | $35.64 | $33.16 | $35.64 | +38.72% |
| December, 2025 | $38.25 | $35.83 | $38.58 | +48.90% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2026
The predicted value for Tema Oncology Etf (CANC) in 2026 is set at an average of $40.98. Estimates vary from a peak of $45.63 to a trough of $36.34, indicating an +59.53% surge from the present price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $38.28 | $37.46 | $38.75 | +48.99% |
| February, 2026 | $40.14 | $38.26 | $40.34 | +56.22% |
| March, 2026 | $40.61 | $39.98 | $41.52 | +58.09% |
| April, 2026 | $38.95 | $38.95 | $40.73 | +51.62% |
| May, 2026 | $39.10 | $38.01 | $40.18 | +52.19% |
| June, 2026 | $36.34 | $36.34 | $38.16 | +41.44% |
| July, 2026 | $38.74 | $36.62 | $38.74 | +50.80% |
| August, 2026 | $41.12 | $38.40 | $41.48 | +60.04% |
| September, 2026 | $41.83 | $40.68 | $42.73 | +62.83% |
| October, 2026 | $43.42 | $41.95 | $43.43 | +69.02% |
| November, 2026 | $45.23 | $42.70 | $45.63 | +76.05% |
| December, 2026 | $43.90 | $43.59 | $44.93 | +70.88% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tema Oncology Etf (CANC) is $44.93, with a high forecast of $49.75 and a low forecast of $40.11. This indicates an +74.88% increase from the last price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $43.71 | $42.26 | $44.26 | +70.13% |
| February, 2027 | $40.95 | $40.81 | $44.48 | +59.38% |
| March, 2027 | $42.21 | $40.11 | $42.41 | +64.29% |
| April, 2027 | $44.08 | $42.12 | $44.30 | +71.59% |
| May, 2027 | $46.05 | $44.06 | $46.48 | +79.25% |
| June, 2027 | $46.70 | $45.47 | $47.00 | +81.77% |
| July, 2027 | $48.80 | $46.79 | $49.75 | +89.96% |
| August, 2027 | $48.40 | $47.77 | $49.36 | +88.39% |
| September, 2027 | $47.28 | $46.52 | $49.13 | +84.03% |
| October, 2027 | $45.18 | $44.77 | $48.78 | +75.84% |
| November, 2027 | $46.04 | $43.88 | $46.15 | +79.22% |
| December, 2027 | $47.80 | $44.62 | $47.80 | +86.06% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2028
In 2028, Tema Oncology Etf (CANC) is projected to reach an average price of $52.76, with a high projection of $57.99 and a low estimate of $47.54. This indicates an +105.37% rise from the last price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $50.11 | $47.54 | $50.43 | +95.05% |
| February, 2028 | $50.33 | $49.47 | $50.70 | +95.92% |
| March, 2028 | $52.60 | $50.36 | $52.65 | +104.73% |
| April, 2028 | $52.15 | $52.12 | $53.87 | +102.98% |
| May, 2028 | $50.78 | $50.77 | $53.33 | +97.64% |
| June, 2028 | $49.20 | $48.49 | $53.09 | +91.51% |
| July, 2028 | $48.51 | $47.65 | $49.42 | +88.84% |
| August, 2028 | $51.12 | $48.44 | $51.12 | +98.96% |
| September, 2028 | $53.51 | $51.44 | $53.51 | +108.28% |
| October, 2028 | $53.84 | $53.47 | $54.69 | +109.56% |
| November, 2028 | $56.48 | $54.00 | $56.68 | +119.83% |
| December, 2028 | $57.22 | $56.38 | $57.99 | +122.73% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2029
The 2029 price forecast for Tema Oncology Etf Stock (CANC) is $56.76 on average, with a high prediction of $62.11 and a low estimate of $51.42. This represents an +120.94% increase from the previous price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $55.89 | $55.89 | $57.53 | +117.55% |
| February, 2029 | $56.20 | $55.02 | $57.39 | +118.76% |
| March, 2029 | $51.42 | $51.42 | $53.18 | +100.13% |
| April, 2029 | $53.72 | $51.76 | $53.87 | +109.09% |
| May, 2029 | $56.79 | $53.67 | $57.16 | +121.06% |
| June, 2029 | $58.39 | $56.43 | $58.67 | +127.30% |
| July, 2029 | $58.86 | $57.47 | $59.14 | +129.09% |
| August, 2029 | $61.77 | $59.04 | $62.11 | +140.43% |
| September, 2029 | $61.73 | $60.33 | $61.73 | +140.27% |
| October, 2029 | $60.84 | $59.27 | $61.74 | +136.83% |
| November, 2029 | $55.96 | $55.83 | $61.69 | +117.81% |
| December, 2029 | $56.45 | $55.19 | $57.69 | +119.71% |
Tema Oncology Etf Stock (CANC) Price Forecast for 2030
Tema Oncology Etf Stock (CANC) is expected to reach an average price of $62.71 in 2030, with a high forecast of $68.93 and a low forecast of $56.49. This signifies an +144.09% surge from the last price of $25.69.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $59.69 | $56.49 | $59.91 | +132.35% |
| February, 2030 | $61.93 | $59.73 | $62.33 | +141.05% |
| March, 2030 | $62.47 | $61.47 | $63.14 | +143.15% |
| April, 2030 | $64.90 | $62.67 | $64.96 | +152.63% |
| May, 2030 | $65.14 | $64.51 | $66.23 | +153.54% |
| June, 2030 | $63.53 | $63.52 | $65.96 | +147.29% |
| July, 2030 | $60.12 | $59.65 | $65.99 | +134.02% |
| August, 2030 | $61.25 | $58.96 | $61.36 | +138.43% |
| September, 2030 | $62.72 | $59.90 | $62.72 | +144.15% |
| October, 2030 | $65.92 | $63.15 | $66.24 | +156.59% |
| November, 2030 | $66.41 | $65.48 | $66.65 | +158.49% |
| December, 2030 | $68.73 | $66.50 | $68.93 | +167.53% |
0.60%
Cap:
|
Volume (24h):